Ampicillin Injection, Powder, For Solution
NDC Package 0404-9760-99

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Ampicillin (ampicillin sodium) injection is ampicillin is used to treat a wide variety of bacterial infections. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Henry Schein, Inc., this product is identified by NDC 0404-9760 and is authorized under FDA application ANDA065499.

Identification & Billing

NDC Package Code
0404-9760-99
Package Description
1 VIAL in 1 BAG / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product Code
0404-9760
11-Digit Billing Format
00404976099

Clinical Specifications

Proprietary Name
Ampicillin
Non-Proprietary Name
Ampicillin Sodium
Substance Name
Ampicillin Sodium
Dosage Form
Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
AMPICILLIN SODIUM 1 g/1
Pharmacologic Class
Usage Information
Ampicillin is used to treat a wide variety of bacterial infections. It is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Henry Schein, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA065499
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-31-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0404-9760-99 identifies a specific commercial package of 1 vial in 1 bag / 1 injection, powder, for solution in 1 vial of Ampicillin, a human prescription drug labeled by Henry Schein, Inc.. This injection, powder, for solution is formulated for intramuscular; intravenous use and contains ampicillin sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Henry Schein, Inc. on July 31, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Ampicillin is used to treat a wide variety of bacterial infections. It is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Henry Schein, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00404976099. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0404-9760-99
11-Digit CMS (5-4-2)
00404-9760-99

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.